Definition
Antiretroviral medication(s): There are currently five main groups of antiretroviral (ARV) medications used to treat HIV. They are called ARV medications because they act against the life cycle of the retrovirus HIV. The five groups are as follows (of note, they are categorized by how they interfere with the HIV life cycle with the sixth group/designation “multi-class combination products” containing different combinations of ARV medications from the main groups working against various components of the HIV life cycle):
- 1.
Entry inhibitors: ARV medications in this class of ARVs effectively interfere with the receptor-mediated entry of the HIV virus into a cell. One subclass of entry inhibitors is the CCR5 antagonists; and the one medication approved for use currently in this subclass is maraviroc, with viroc standing for virus occupying. A new medication in this class, cenicriviroc, is currently in preclinical studies and may be available soon.
...
This is a preview of subscription content, log in via an institution.
References
Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(1):1–10.
Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370(26):2487–98. Available at http://www.ncbi.nlm.nih.gov/pubmed/24963568.
Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-Ntege P, Keishanyu R, Nathoo K, the Antiretroviral Research for Watoto (ARROW) Trial Team. A randomized trial of stopping or continuing co-trimoxazole in HIV-infected children. N Engl J Med. 2014;370:41–53.
Campbell JD, Moore D, Degerman R, Kaharuza F, Were W, Muramuzi E, et al. HIV-infected Ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue co-trimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012;54:1204–11.
Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21767103.
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach – Second edition; released/published http://www.who.int/hiv/pub/arv/arv-2016/en/. Updated/released June 2016.
Grant RM, Lama JR, Anderson PL, iPrEx Study Team, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99. PMID: 21091279.
Inker LA, Schmid CH, Tighiouart H, for the CKD-EPI Investigators, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9. PMID: 22762315.
INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807. Available at http://www.ncbi.nlm.nih.gov/pubmed/26192873.
Makadzange AT, Ndhlovu CE, Takarinda K, et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa. Clin Infect Dis. 2010;50(11):1532–8. Available at http://www.ncbi.nlm.nih.gov/pubmed/20415574.
Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358(6):568–79.
Martin AM, Almeida CA, Cameron P, et al. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS. 2007;21(10):1233–44.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council (OARAC) and last updated July 14th, 2016. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 22 Aug 2017.
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 22 Aug 2017; pp 160–170.
Polyak CS, Yuhas K, Singa B, Khaemba M, Watson J, Richardson B et al. CTX prophylaxis discontinuation among ART treated adults: a randomized non-inferiority trial. In: Twenty-first conference on retroviruses and opportunistic infections (CROI), Boston, 3–6 Mar 2014 [Abstract 98]. http://www.croiconference.org/sites/default/files/abstracts/98.pdf. Accessed 11 Nov 2015.
TEMPRANO ANRS Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–22. Available at http://www.ncbi.nlm.nih.gov/pubmed/26193126.9.
Thigpen MC, Rose CE, Paxton LA. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med. 2013;368(1):82–3.
UNAIDS fact sheet (released July 2017). Available at: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.
Wester CW, Bussmann H, Koethe J, Moffat C, Vermund SH, Essex M, Marlink RG. Combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther. 2009;3(5):501–26.
Zolopa A, Andersen J, Powderly W, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009;4(5):e5575. Available at http://www.ncbi.nlm.nih.gov/pubmed/19440326.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
William Wester, C. (2017). Antiretroviral Medications, Adult Care, and Treatment. In: Hope, T., Richman, D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_166-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_166-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9610-6
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine